Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
This brief overview contrasts lifecycle funds with target date funds, highlighting key distinctions to help you choose the right fund for retirement planning.
18,693 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
C3.ai has faced a dramatic 2026 drop, leaving investors wondering if the stock is a hidden bargain or a value trap. T...
New emails show Joe Lonsdale offered a privately funded pilot tunnel in Austin, with a pathway to a larger citywide s...
Pi Network announces a major protocol upgrade that advances the mainnet and smart-contract potential, but PI remains ...
A Live Oak Bancshares director sold 8,400 shares for about $336,000. Learn what this kind of insider action can signa...
As vernova's next earnings report approaches, traders and long-term investors weigh margin trends, project momentum, ...
Lyft delivers a dual narrative after Q4 2025: growing bookings and riders on one hand, while a sharp stock decline an...
A new proposal aims to end blind signing in Ethereum wallets. The change could reduce scam losses and tighten securit...
UPS has faced a rough stretch, but signs of a turnaround are catching investor attention. This guide explains why Jul...
Microsoft shares have fallen sharply this year, yet bulls argue that cloud growth and AI initiatives underpin a resil...
When Burke & Herbert shares jump, investors want to know why. This article breaks down what this burke herbert signal...
Prediction markets hint at a tiny chance of Bitcoin reaching $150K by June. This article explains why those odds exis...